Moran Susan has filed 6 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 9023 shares of CRESCENT BIOPHARMA, INC. ($CBIO) on June 23, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 23, 2025 | CRESCENT BIOPHARMA, INC. | $CBIO | Moran Susan | Director | A | Stock Option (Right to Buy) | 9023 | $0.00 | 9,023.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2025 | BioAtla, Inc. | $BCAB | Moran Susan | Not found | A | Common Stock | 23500 | $0.00 | 52,307.0000 | 58,099,164 | 81.58% | 0.04% |
| May 29, 2025 | Tyra Biosciences, Inc. | $TYRA | Moran Susan | Not found | A | Stock Option (Right to Buy) | 22200 | $0.00 | 22,200.0000 | 57,217,746 | 9999.99% | 0.04% |
| June 13, 2024 | BioAtla, Inc. | $BCAB | Moran Susan | Not found | A | Common Stock | 16500 | $0.00 | 28,807.0000 | 48,077,599 | 134.07% | 0.03% |
| May 7, 2024 | Tyra Biosciences, Inc. | $TYRA | Moran Susan | Not found | A | Common Stock (Right to Buy) | 37200 | $0.00 | 37,200.0000 | 42,704,876 | 9999.99% | 0.09% |
| June 14, 2023 | BioAtla, Inc. | $BCAB | Moran Susan | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |